UnitedHealth Group Inc. (NYSE: UNH) and lawyers from the U.S. Department of Justice made closing arguments Thursday in a trial over whether the insurance giant will be allowed to proceed with its multibillion-dollar acquisition of Change Healthcare, with the judge in the case showing some skepticism of the government's challenge to the deal.
The Wall Street Journal has a report on the end of arguments in the federal antitrust trial, which began a month ago.
UnitedHealth's bid to buy Nashville-based…
